期刊
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
卷 95, 期 -, 页码 86-93出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.yjmcc.2015.11.019
关键词
Cardiac hypertrophy; Heart failure; Remodeling
资金
- NIH [HL-120732, HL-100401]
- AHA [14SFRN20740000]
- CPRIT [RP110486P3]
- Leducq Foundation [11CVD04]
Autophagy is an evolutionarily ancient process of intracellular catabolism necessary to preserve cellular homeostasis in response to a wide variety of stresses. In the case of post-mitotic cells, where cell replacement is not an option, finely tuned quality control of cytoplasmic constituents and organelles is especially critical. And due to the ubiquitous and critical role of autophagic flux in the maintenance of cell health, it comes as little surprise that perturbation of the autophagic process is observed in multiple disease processes. A large body of preclinical evidence suggests that autophagy is a double-edged sword in cardiovascular disease, acting in either beneficial or maladaptive ways, depending on the context. In light of this, the autophagic machinery in cardiomyocytes and other cardiovascular cell types has been proposed as a potential therapeutic target. Here, we summarize current knowledge regarding the dual functions of autophagy in cardiovascular disease. We go on to analyze recent evidence suggesting that titration of autophagic flux holds potential as a novel treatment strategy. (C) 2015 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据